NASDAQ:IVTY

Invuity (IVTY) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$7.39
$7.39
50-Day Range
N/A
52-Week Range
$2.35
$9.55
Volume
N/A
Average Volume
324,995 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IVTY stock logo

About Invuity Stock (NASDAQ:IVTY)

Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities. It offers various illuminated surgical devices, including Eikon LT illuminated retractor system for breast/oncoplastic/gynecology/EP/plastic/endocrine surgeries; Eiberg illuminated retractor systems for orthopedic surgeries; PhotonBlade, a recision illuminator for breast/plastics/EP/orthopedics surgeries; PhotonSaber Y, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general/gynecology/plastic surgeries; and PhotonSaber F, a handheld illuminator for spine/orthopedic/neurosurgery surgeries. The company also provides Breiten illuminated retractor systems for spine/orthopedic surgeries; Photonguide XT system, a drop-in intracavity illuminator for spine surgeries; Eika illuminated retractor systems for endocrine/spine/orthopedic surgeries; and PhotonVue, a system used in conjunction with IC Indocyanine for identifying and verifying blood flow in tissue, as well as is used in breast/plastic/colorectal surgeries. It sells its devices through direct sales representatives and independent sales agents; and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. The company was formerly known as Spotlight Surgical, Inc. and changed its name to Invuity, Inc. in 2007. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California.

IVTY Stock News Headlines

Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Study: Ivy League Colleges Aren’t Worth It
Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
FLG Partners Increases Capacity for Growth
See More Headlines
Receive IVTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invuity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/02/2018
Today
4/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:IVTY
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Scott D. Flora (Age 62)
    Interim Pres, CEO & Director
  • Mr. Philip M. Sawyer (Age 53)
    CEO, Pres & Director
  • Mr. James H. MacKaness (Age 54)
    Chief Financial Officer
  • Mr. Douglas W. Heigel (Age 57)
    Sr. VP of Operations
  • Ms. Marcia Fish (Age 54)
    Chief HR Officer

IVTY Stock Analysis - Frequently Asked Questions

How were Invuity's earnings last quarter?

Invuity, Inc. (NASDAQ:IVTY) issued its earnings results on Thursday, August, 2nd. The medical instruments supplier reported ($0.37) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.47) by $0.10. The medical instruments supplier had revenue of $10.50 million for the quarter, compared to analysts' expectations of $10.73 million.

What other stocks do shareholders of Invuity own?
When did Invuity IPO?

Invuity (IVTY) raised $48 million in an initial public offering on the week of June 15th 2015. The company issued 4,000,000 shares at a price of $12.00 per share. Piper Jaffray, Leerink Partners and Stifel acted as the underwriters for the IPO and William Blair was co-manager.

This page (NASDAQ:IVTY) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners